The Medvi Miracle: How One Founder’s Hands-On AI Strategy (Not Automation) Built a $1.8 Billion Telehealth Empire

In the high-stakes world of telehealth and weight-loss solutions, Medvi has become a case study in explosive growth. Founded by Matthew Gallagher from his Los Angeles home, Medvi—a platform offering compounded GLP-1 medications like semaglutide and tirzepatide—generated $401 million in revenue in its first full year of 2025 with just 250,000 customers. Projections for 2026 sit at a staggering $1.8 billion. That’s roughly $3 million in daily sales. And it was achieved with essentially two full-time people: Gallagher and his brother Elliot. No massive VC funding. No bloated team. Just $20,000, two months of intense work, and a deliberate, strategic application of AI.

This isn’t hype. It’s a masterclass in lean efficiency powered by AI generative media. But here’s the crucial detail that separates Medvi’s success from the flood of AI startup myths: founder Matthew Gallagher did not rely on any automated marketing tools or “set it and forget it” AI agents. In fact, avoiding those tools was a direct contributor to his meteoric rise. The weight-loss drugs Medvi sells are commoditized—essentially the same compounded GLP-1 formulations available from dozens of competitors. In a market like this, the only real moat is marketing, distribution, and trust. Gallagher built that moat through hands-on oversight of generative AI, not blind automation. Had he leaned on the many fully autonomous marketing agents and tools hyped today, his brand likely would have tanked. No one trusts obvious AI slop, especially when health and prescriptions are on the line.

Let’s go back to the launch in September 2024. Gallagher spotted the gap: brand-name Ozempic and Wegovy were too expensive for most people, while telehealth compounded alternatives offered accessibility. Building a compliant, professional platform in just two months seemed impossible—until AI entered the picture. He turned to more than a dozen generative tools. Large language models like ChatGPT, Claude, and Grok wrote the website code, backend systems, product descriptions, and customer service scripts. Midjourney and Runway generated the initial eye-catching images and videos—smiling patients, dramatic transformations, polished ad creatives that looked like they came from a Madison Avenue agency. ElevenLabs cloned his voice for appointment scheduling calls. He even built custom AI agents to connect disparate systems so everything communicated seamlessly.

The efficiency was game-changing. AI chatbots handled 24/7 inquiries. Onboarding, consultations (via partnered licensed doctors through OpenLoop Health and CareValidate), prescriptions, and shipping all ran with minimal human intervention. But—and this is the part most AI evangelism glosses over—Gallagher never handed the reins to fully automated marketing systems. He reviewed, refined, and iterated on every single asset himself. Early chatbot hallucinations (suggesting unrelated recipes instead of medical guidance) were caught and fixed through meticulous prompt engineering and human oversight. Initial AI-generated before-and-after photos on the homepage? He personally swapped many of them out for real customer testimonials once sales allowed. Even the cheeky media logo ticker on the site, implying big press coverage, was a calculated, human-approved touch—not some autonomous campaign running wild.

This hands-on approach was no accident. Gallagher understood that in the sensitive space of weight loss and telehealth, authenticity matters more than speed. Fully automated “set it and forget it” marketing agents—those that blast out generic copy, unvetted images, or repetitive ad sequences without human review—produce what critics rightly call AI slop: inauthentic, soulless, sometimes hallucinated content that screams “low effort.” Consumers are savvy. They spot robotic emails, uncanny-valley visuals, and overly polished but empty messaging instantly. In a health category where trust can make or break a prescription decision, slop doesn’t just fail to convert—it actively repels customers and invites regulatory scrutiny or social backlash. Medvi’s competitors who chased pure automation learned this the hard way through FDA warning letters and customer complaints about misleading AI-generated promotions. Gallagher’s refusal to go that route protected his brand’s credibility from day one.

By keeping himself in the loop, Gallagher turned AI into a superpower rather than a liability. Generative tools let one person produce marketing assets at a scale that would normally require entire creative teams. He flooded social media, search, and display networks with scroll-stopping visuals and persuasive copy. The website featured emotionally resonant journeys that converted browsers into buyers at record speed. Early results snowballed: 300 customers in month one, over 1,000 in month two. As revenue poured in, he layered professional ad agencies on top—but the foundation remained his strategic, oversight-driven use of generative AI. No autonomous agents deciding ad spend or tweaking campaigns unsupervised. Just a founder who moved fast, tested rigorously, and infused every output with human judgment.

The numbers prove it worked. Medvi ended 2025 with a healthy 16.2% net profit margin (about $65 million) and zero outside funding. Operations stayed razor-thin. AI handled the repetitive heavy lifting, but Gallagher’s brother joined as the only other full-time team member to help prioritize and filter the flood of communications. It was super efficient—and, as Gallagher has noted in interviews, occasionally lonely. Yet that loneliness came with unmatched speed and control. He outsourced only what AI couldn’t safely touch: licensed medical oversight, pharmacy fulfillment, and legal compliance.

Here’s the broader lesson for every business owner: In commoditized markets, marketing and distribution are everything. But the winners won’t be those who outsource their voice to fully autonomous AI agents. They’ll be the ones who use generative tools the Medvi way—strategically, with constant human direction. Pure automation might save time on paper, but it erodes trust, especially in regulated or high-stakes industries. AI slop doesn’t build loyalty; it triggers skepticism. Gallagher’s success shows that the real moat is thoughtful application: generate fast, review ruthlessly, refine relentlessly.

This philosophy is exactly why tools like Orbital Marketing AI (https://orbitalmarketing.ai) stand out as the next-level solution. Unlike the set-it-and-forget-it agents that could have doomed Medvi, Orbital is designed as your intelligent collaborator—not a replacement for judgment. It generates high-converting sales copy, emails, blog posts, ad scripts, and social content that feels human because you guide the process every step. Its AI Images and AI Videos tools create stunning, royalty-free visuals and realistic promotional videos complete with audio—perfect for ads, websites, and campaigns. You can edit with simple text prompts, translate instantly, organize assets in one hub, and tap into top models like GPT-4, Claude 3.

What sets Orbital apart is the balance it strikes: lightning-fast creation without sacrificing control. Users report producing months of content in hours, breaking creative blocks, and outperforming traditional agencies. Templates, data uploads for personalization, and upcoming agentic workflows automate the tedious parts while keeping you firmly in the driver’s seat—exactly the Medvi playbook. No more generic slop. No more risking brand trust. Just powerful generative media that you refine into authentic, converting campaigns.

Imagine applying this to your business. Launch targeted ads in days, not months. Test dozens of variations overnight. Create personalized journeys at scale. All while staying lean and maintaining the human touch that builds real trust. Whether you sell supplements, software, e-commerce products, or services, the Medvi story proves that AI generative media is the ultimate accelerator—when used strategically, not autonomously.

Of course, AI still requires smart guardrails. Gallagher monitored outputs, iterated on failures, and brought in experts where needed. That’s the winning formula, and it’s precisely what Orbital enables without the complexity.

Medvi’s trajectory isn’t luck or a one-off. It’s the blueprint for the AI-driven economy: lean teams, generative tools for media and marketing, and zero tolerance for slop. The drugs may be the same everywhere, but the story you tell, the visuals you craft, and the trust you earn? That’s where fortunes are made.

If you’re ready to replicate that success without the pitfalls of automation, visit Orbital Marketing AI at https://orbitalmarketing.ai today. Start with their free trial and experience how human-directed AI can elevate your marketing—and your revenue—to the next level.

The Medvi story is still unfolding. With the right approach to generative AI, your business could be next.